Integrative Computational Analysis of Viral Glycoprotein Evolution and Antibody Escape Dynamics

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-05-10

Key Takeaways

• Integrative computational analysis leverages sequence surveillance, phylogenetic reconstruction, structural biology, and biophysical simulations to characterize viral glycoprotein evolution and predict antibody escape dynamics at molecular resolution.
• Phylogenetic analysis, including dN/dS ratio calculations, identifies codons under positive selection, often corresponding to antibody epitopes or receptor-binding interfaces, indicating immune evasion.
• Molecular dynamics (MD) simulations and free energy perturbation calculations elucidate glycoprotein conformational ensembles and quantitatively assess mutation-induced changes in binding affinity to host receptors or antibodies, identifying escape hotspots.
• Deep mutational scanning (DMS) experimentally maps the fitness and antibody escape phenotype of numerous mutations, providing data for machine learning models that predict escape mutations and generalize to unobserved variants.
• Computational methods are crucial for assessing zoonotic spillover risk by modeling receptor binding across species and for guiding vaccine design by identifying conserved, escape-resistant epitopes and optimizing immunogen structures.
• Insertions and deletions (indels) in glycoprotein genes, particularly in hypervariable regions, are increasingly recognized as drivers of antigenic change and can be computationally predicted to assess their structural and functional impact.

Introduction

Viral glycoproteins are the primary determinants of host cell tropism and the principal targets of neutralizing antibody responses in infected or vaccinated hosts [<a href="#ref-1">1</a>]. Their continuous evolution under selective pressure from host immunity drives antigenic drift, necessitating iterative updates to veterinary vaccines and diagnostic reagents [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. Integrative computational analysis now combines sequence surveillance, phylogenetic reconstruction, structural biology, and biophysical simulation to characterise glycoprotein evolution and predict antibody escape dynamics at molecular resolution [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. This article reviews the key computational methodologies and their application to veterinary pathogens, with emphasis on cross-species transmission risk and vaccine design.

Sequence Surveillance and Phylogenetic Analysis

High-throughput sequencing of viral genomes from clinical and environmental samples provides the raw material for evolutionary analysis [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. For veterinary applications, global databases such as GISAID (for influenza A viruses) and community-curated repositories for coronaviruses and other pathogens enable real-time monitoring of amino acid substitutions in glycoprotein genes [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>]. Routine variant calling pipelines identify single nucleotide polymorphisms and insertion-deletion events that may alter receptor binding or antigenicity [<a href="#ref-8">8</a>, <a href="#ref-10">10</a>].

Phylogenetic inference using maximum likelihood or Bayesian frameworks reconstructs the evolutionary history of glycoprotein lineages [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. For example, analysis of avian infectious bronchitis virus (IBV) spike protein sequences from broiler flocks in Uzbekistan revealed the co-circulation of GI-1, GI-13, and GI-23 genotypes, each exhibiting distinct patterns of amino acid variation in the hypervariable regions of the S1 subunit [<a href="#ref-11">11</a>]. Similarly, whole-genome phylogenetics of chicken infectious anemia virus isolates from Egyptian poultry identified lineage-specific mutations in the VP1 capsid protein that correlate with altered pathogenicity [<a href="#ref-12">12</a>].

Evolutionary rate estimation and selection pressure analyses (dN/dS ratios) pinpoint codons under positive selection, often corresponding to antibody epitopes or receptor-binding interfaces [<a href="#ref-8">8</a>, <a href="#ref-10">10</a>]. Recurrent mutations at such sites are hallmarks of immune evasion [<a href="#ref-10">10</a>]. Computational pipelines that integrate phylogenetics with structural mapping help prioritise mutations for functional characterisation [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. For a detailed discussion of mutation rate modeling, refer to the article on Evolutionary Dynamics and Computational Modeling of Viral Mutation Rates.

Structural Modeling and Molecular Dynamics

Three-dimensional structures of viral glycoproteins, obtained experimentally via cryo-electron microscopy or X-ray crystallography, or predicted computationally using tools such as AlphaFold2, serve as templates for mechanistic studies [<a href="#ref-14">14</a>, <a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. Homology modeling and ab initio methods extend structural coverage to less characterised veterinary viruses [<a href="#ref-4">4</a>, <a href="#ref-17">17</a>].

Molecular dynamics (MD) simulations allow the exploration of glycoprotein conformational ensembles on microsecond to millisecond timescales [<a href="#ref-18">18</a>, <a href="#ref-19">19</a>]. All-atom MD with explicit solvent reveals the dynamic behaviour of receptor-binding domains (RBDs), including loop motions, domain rotations, and exposure of cryptic epitopes [<a href="#ref-15">15</a>, <a href="#ref-20">20</a>]. For the SARS-CoV-2 spike protein, MD simulations have elucidated how mutations such as N481K alter the conformational equilibrium of the RBD, affecting both ACE2 receptor affinity and antibody recognition [<a href="#ref-21">21</a>]. Similarly, simulations of influenza hemagglutinin (HA) have mapped the pH-induced conformational changes required for membrane fusion [<a href="#ref-3">3</a>].

Free energy perturbation and alchemical calculations provide quantitative estimates of mutation-induced changes in binding free energy between glycoproteins and host receptors or antibodies [<a href="#ref-5">5</a>, <a href="#ref-18">18</a>]. The hierarchical mutational profiling approach described by Alshahrani et al. systematically evaluates the energetic impact of every possible amino acid substitution at an antibody-glycoprotein interface, identifying escape hotspots that confer resistance without compromising receptor binding [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-19">19</a>, <a href="#ref-20">20</a>, <a href="#ref-22">22</a>]. These calculations often rely on the MM/GBSA or MM/PBSA methods applied to MD trajectories [<a href="#ref-23">23</a>].

The integration of MD with metadynamics or replica exchange enhances sampling of rare events relevant to immune evasion, such as the opening of the receptor-binding site or the repositioning of glycans that shield epitopes [<a href="#ref-24">24</a>]. Glycan shielding itself is a dynamic process; computational models that account for glycan flexibility are essential for predicting antibody accessibility [<a href="#ref-24">24</a>]. For further details on simulation techniques, consult the article on Molecular Dynamics Simulations of Viral Spike Glycoproteins: Insights into Host Receptor Binding and Antibody Escape.

Predicting Antibody Escape Mutations

Epitope Mapping and Mutational Profiling

Deep mutational scanning (DMS) experimentally measures the fitness and antibody escape phenotype of thousands of single amino acid substitutions in a glycoprotein [<a href="#ref-25">25</a>, <a href="#ref-26">26</a>]. Computational models trained on DMS data can generalise to predict escape mutations not yet observed in nature [<a href="#ref-25">25</a>, <a href="#ref-26">26</a>]. Bayesian active learning, combined with biophysical features, has been used to prioritise high-fitness viral variants for experimental validation, accelerating the identification of emerging escape variants [<a href="#ref-25">25</a>].

Structural analysis of antibody-glycoprotein complexes reveals the specific contacts that define neutralisation breadth [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-19">19</a>]. Broadly neutralising antibodies (bnAbs) often target conserved, functionally constrained epitopes such as the receptor-binding site or the fusion peptide [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>]. Resistance to bnAbs can arise through direct epitope erosion (loss of contact residues) or through allosteric modulation of the epitope conformation [<a href="#ref-16">16</a>, <a href="#ref-19">19</a>, <a href="#ref-22">22</a>]. The frustration landscape concept, which quantifies the energetic frustration of residue interactions in the antibody-antigen interface, has been applied to distinguish escape-prone from escape-proof epitopes [<a href="#ref-22">22</a>].

Machine learning classifiers trained on structural and energetic features can predict whether a given mutation will reduce antibody binding [<a href="#ref-26">26</a>, <a href="#ref-29">29</a>]. Features include changes in buried surface area, hydrogen bonding networks, van der Waals contacts, and local electrostatic potential [<a href="#ref-29">29</a>]. For Omicron variants of SARS-CoV-2, such models correctly identified mutations that confer resistance to class I and class IV neutralizing antibodies [<a href="#ref-6">6</a>, <a href="#ref-14">14</a>, <a href="#ref-20">20</a>]. The same framework is transferable to veterinary coronaviruses such as porcine epidemic diarrhea virus (PEDV) and feline infectious peritonitis virus (FIPV) by homology.

Role of Insertions and Deletions

Insertions and deletions (indels) in glycoprotein genes, particularly in hypervariable regions, are increasingly recognised as drivers of antigenic change [<a href="#ref-8">8</a>]. In the SARS-CoV-2 spike protein, indels in the N-terminal domain and the RBD have been associated with altered glycan shield architecture and antibody evasion [<a href="#ref-8">8</a>, <a href="#ref-30">30</a>]. Computational prediction of the structural impact of indels is more challenging than for point mutations but can be addressed through flexible loop modeling and MD refinement [<a href="#ref-13">13</a>]. The functional relevance of such indels in animal coronaviruses (e.g., the S1/S2 cleavage site insertions in bat coronaviruses) underscores their importance in zoonotic potential [<a href="#ref-30">30</a>].

For an expanded discussion of deep mutational scanning and machine learning in the context of antibody escape, see the article on Deep Mutational Scanning and Machine Learning for Predicting SARS-CoV-2 Spike Protein Evolution and Antibody Escape.

Zoonotic Spillover Risk and Vaccine Design

Computational analysis of glycoprotein evolution directly informs assessments of zoonotic spillover risk [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. Comparative structural modeling of ACE2 orthologues across mammalian species, combined with molecular docking, predicts which animal hosts are susceptible to a given coronavirus [<a href="#ref-1">1</a>]. For example, the broad host range of SARS-CoV-2 was anticipated by sequence and structural comparisons of ACE2 from diverse vertebrates [<a href="#ref-1">1</a>]. Similarly, analysis of HA receptor-binding specificity determines whether an avian influenza virus can bind human-type sialic acid receptors, a prerequisite for pandemic potential [<a href="#ref-3">3</a>]. Methods for predicting receptor-binding dynamics across species are reviewed in the article on Computational Prediction of Viral Entry Dynamics: Spike Protein-Receptor Binding Affinity and Escape Mutations.

Vaccine design benefits from computational identification of epitopes that are both conserved across circulating strains and resistant to escape [<a href="#ref-5">5</a>, <a href="#ref-27">27</a>, <a href="#ref-31">31</a>]. Immunoinformatic pipelines predict B-cell and T-cell epitopes from glycoprotein sequences and filter them for conservation, population coverage, and structural accessibility [<a href="#ref-31">31</a>]. Structure-based design of immunogens that stabilise the prefusion conformation of fusion proteins (e.g., respiratory syncytial virus F protein, coronavirus spike) has been guided by MD simulations and free energy calculations [<a href="#ref-16">16</a>, <a href="#ref-23">23</a>].

Nanobodies and other small binding proteins can be computationally optimised for broad neutralisation using Rosetta or deep learning approaches [<a href="#ref-23">23</a>]. For instance, computational optimisation of a nanobody targeting the SARS-CoV-2 RBD improved binding affinity and breadth across variants while reducing the potential for escape [<a href="#ref-23">23</a>]. Such strategies are directly applicable to veterinary pathogens for which monoclonal antibody therapeutics are being developed [<a href="#ref-28">28</a>].

Table 1 summarises the key computational methods discussed and their primary applications in glycoprotein evolution and antibody escape prediction.

Table 1. Computational Methods for Viral Glycoprotein Analysis

Integrated Workflow

Figure 1 presents a Mermaid workflow that integrates the computational approaches described in this review, from sequence acquisition to actionable predictions for surveillance and vaccine design.

flowchart TD
 A["Viral Sequence Data"] --> B["Variant Calling & Quality Control"]
 B --> C["Phylogenetic Reconstruction"]
 C --> D["Selection Analysis dN/dS"]
 D --> E["Identify Positively Selected Sites"]
 E --> F["Map to 3D Glycoprotein Structure"]
 F --> G["Molecular Dynamics Simulations"]
 G --> H["Free Energy Calculations for Mutations"]
 H --> I["Predict Antibody Escape Mutations"]
 I --> J["Machine Learning Escape Classifier"]
 J --> K["Validate with Deep Mutational Scanning"]
 K --> L["Update Surveillance Targets"]
 L --> M["Guide Vaccine Strain Selection"]

The workflow begins with sequence data from field isolates or experimental passages [<a href="#ref-2">2</a>, <a href="#ref-7">7</a>]. After variant calling [<a href="#ref-8">8</a>], phylogenetic analysis identifies lineages and selection pressures [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. Positively selected sites are mapped to available structures [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. MD simulations and free energy calculations evaluate the functional impact of mutations [<a href="#ref-6">6</a>, <a href="#ref-18">18</a>]. Machine learning classifiers integrate these data to predict escape [<a href="#ref-26">26</a>, <a href="#ref-29">29</a>]. Predictions can be tested experimentally via DMS [<a href="#ref-25">25</a>] and fed back into surveillance and vaccine design [<a href="#ref-31">31</a>].

Integration with Structural Databases and Visualization

Interactive 3D visualisation tools, such as the 3D Protein Viewer integrated into this portal, allow readers to inspect glycoprotein structures and antibody complexes. Users can load coordinates of influenza HA, coronavirus spike, or other veterinary glycoproteins and highlight residues under positive selection or predicted as escape hotspots. For example, the RBD of the SARS-CoV-2 spike protein with the N481K mutation can be visualised to understand its impact on antibody binding [<a href="#ref-21">21</a>]. Readers are encouraged to explore the article on Computational Prediction of Viral Glycoprotein Dynamics: From Sequence to 3D Structure and Immune Evasion for a tutorial on structural analysis.

Cross-referencing with databases such as GISAID for influenza and the ESC resource for SARS-CoV-2 immune escape variants [<a href="#ref-9">9</a>] provides additional context for veterinary virologists monitoring emerging strains.

Conclusion

Integrative computational analysis of viral glycoprotein evolution and antibody escape dynamics is essential for understanding antigenic drift, predicting zoonotic spillover risk, and designing effective veterinary vaccines. Sequence surveillance and phylogenetics establish the evolutionary framework, while MD simulations and free energy calculations provide mechanistic insight into the molecular determinants of escape. Machine learning models trained on structural and energetic features generalise these insights to predict future escape mutations. The cross-species applicability of these methods, demonstrated for coronaviruses, influenza viruses, and other veterinary pathogens, underscores their utility in animal health. Continued development of integrated pipelines that combine simulation, machine learning, and experimental validation will accelerate the response to emerging viral threats in both veterinary and comparative medicine.

For further reading on related topics, see the articles on Computational Modeling of Viral Glycoprotein Evolution: Predicting Antigenic Drift Using Machine Learning and Structural and Evolutionary Dynamics of Zoonotic Viral Glycoproteins: Integrating Molecular Modeling, Sequence Surveillance, and Receptor Binding Prediction.

References

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices